UK’s CMA Issues £35m In Fines Over Prochlorperazine
Advanz And Alliance Plan To Appeal Against Decision By Competition Watchdog
Multiple firms have been fined a total of more than £35m by the UK’s competition regulator in connection with an alleged illegal arrangement connected with anti-nausea drug prochlorperazine that led prices to increase by 700%. But Advanz and Alliance have hit back at the decision, revealing plans to appeal.
